Table 2.
Correlation between CD44v6 protein expression and various clinicopathologic parameters.
| Clinicopathologic parameters | Number of cases | CD44v6-positive cases (%) | P value | |
|---|---|---|---|---|
| Age ⩽ 50 > 50 |
21 41 |
13 (61.9) 28 (68.3) |
> 0.05 | |
|
| ||||
| Menopausal status Premenopausal Postmenopausal |
17 45 |
11 (64.7) 30 (66.7) |
> 0.05 | |
|
| ||||
| Nulliparous status Yes No Serous |
9 53 45 |
6 (66.7) 35 (66.0) 32 (71.1) |
> 0.05 | |
|
| ||||
| Histological type Mucinous Endometrioid Undifferentiated |
5 8 4 |
2 (40) 3 (37.5) 4 (100) |
> 0.05 | |
|
| ||||
| FIGO stage I II III IV |
16 23 15 8 |
5 (31.2) 18 (78.2) 11 (73.3) 7 (87.5) |
< 0.05 | |
|
| ||||
| Grade I II III |
19 32 11 |
6 (52.6) 25 (65.6) 10 (90.9) |
< 0.05 | |
|
| ||||
| Survival period ≤ 5 > 5 |
33 29 |
26 (78.8) 15 (51.7) |
< 0.05 | |